373 related articles for article (PubMed ID: 16000561)
41. [Molecular factors promoting carcinogenesis and malignant behavior of intraductal papillary mucinous tumors].
Ichikawa Y; Ueda M; Miura Y; Kunihiro S; Ishikawa T; Endo I; Sekido H; Shimada H
Nihon Geka Gakkai Zasshi; 2003 Jun; 104(6):443-6. PubMed ID: 12854490
[TBL] [Abstract][Full Text] [Related]
42. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
[TBL] [Abstract][Full Text] [Related]
43. Reduced expression of p53 and cyclin A in intraductal mucin-hypersecreting neoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma.
Mukawa K; Kawa S; Aoki Y; Zhai Y; Nikaido T
Am J Gastroenterol; 1999 Aug; 94(8):2263-7. PubMed ID: 10445560
[TBL] [Abstract][Full Text] [Related]
44. Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia.
Abe K; Suda K; Arakawa A; Yamasaki S; Sonoue H; Mitani K; Nobukawa B
Pancreas; 2007 Jan; 34(1):85-91. PubMed ID: 17198188
[TBL] [Abstract][Full Text] [Related]
45. Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Shimamoto F; Sueda T; Hiyama E
J Gastrointest Surg; 2008 Jan; 12(1):17-28; discussion 28-9. PubMed ID: 17960465
[TBL] [Abstract][Full Text] [Related]
46. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
47. Locus/chromosome aberrations in intraductal papillary mucinous neoplasms analyzed by fluorescence in situ hybridization.
Miyabe K; Hori Y; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Yoshida M; Umemura S; Kato A; Ohara H; Joh T; Inagaki H
Am J Surg Pathol; 2015 Apr; 39(4):512-20. PubMed ID: 25517961
[TBL] [Abstract][Full Text] [Related]
48. Intraductal papillary mucinous neoplasm.
Shi C; Hruban RH
Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
[TBL] [Abstract][Full Text] [Related]
49. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
50. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
[TBL] [Abstract][Full Text] [Related]
51. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
[TBL] [Abstract][Full Text] [Related]
52. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia.
Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC
Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632
[TBL] [Abstract][Full Text] [Related]
53. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
[TBL] [Abstract][Full Text] [Related]
54. aPKCλ/ι is a beneficial prognostic marker for pancreatic neoplasms.
Kato S; Akimoto K; Nagashima Y; Ishiguro H; Kubota K; Kobayashi N; Hosono K; Watanabe S; Sekino Y; Sato T; Sasaki K; Nakaigawa N; Kubota Y; Inayama Y; Endo I; Ohno S; Maeda S; Nakajima A
Pancreatology; 2013; 13(4):360-8. PubMed ID: 23890134
[TBL] [Abstract][Full Text] [Related]
55. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features.
Omori Y; Ono Y; Tanino M; Karasaki H; Yamaguchi H; Furukawa T; Enomoto K; Ueda J; Sumi A; Katayama J; Muraki M; Taniue K; Takahashi K; Ambo Y; Shinohara T; Nishihara H; Sasajima J; Maguchi H; Mizukami Y; Okumura T; Tanaka S
Gastroenterology; 2019 Feb; 156(3):647-661.e2. PubMed ID: 30342036
[TBL] [Abstract][Full Text] [Related]
56. Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions.
Funel N; Morelli M; Giovannetti E; Del Chiaro M; Pollina LE; Mosca F; Boggi U; Cavazzana A; Campani D
Pancreatology; 2011; 11(1):30-42. PubMed ID: 21412023
[TBL] [Abstract][Full Text] [Related]
57. Mucin expression profile in pancreatic cancer and the precursor lesions.
Nagata K; Horinouchi M; Saitou M; Higashi M; Nomoto M; Goto M; Yonezawa S
J Hepatobiliary Pancreat Surg; 2007; 14(3):243-54. PubMed ID: 17520199
[TBL] [Abstract][Full Text] [Related]
58. In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.
Kamiyama H; Kamiyama M; Hong SM; Karikari CA; Lin MT; Borges MW; Griffith M; Young A; Norris-Kirby A; Lubek C; Mizuma M; Feldmann G; Shi C; Liang H; Goggins MG; Maitra A; Hruban RH; Eshleman JR
Lab Invest; 2010 May; 90(5):665-73. PubMed ID: 20231822
[TBL] [Abstract][Full Text] [Related]
59. Mucinous cystic neoplasms of the pancreas: pathology and molecular genetics.
Fukushima N; Fukayama M
J Hepatobiliary Pancreat Surg; 2007; 14(3):238-42. PubMed ID: 17520198
[TBL] [Abstract][Full Text] [Related]
60. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
Zhang ML; Lu S; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
